cronos group glp-1 receptor agonist weight management diabetes treatments Agonists For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH Weight Management | GLP-1 Medical

There are concerns about the brain effects of these drugs, particularly in developing brains, due to the significant increase in GLPs, which could have unknown long-term effects on neuroplasticity and learning 4m10s

Manufactured in a UK Facility Synthesised under Strict Laboratory Conditions and Quality Standards

Association between uric acid levels and the risk of futile reperfusion in stroke after thrombectomy: A propensity score matching study

This is an enrollment/operational event no new efficacy data

The observed ability of ipamorelin to influence insulin release suggests that this compound could be of research interest in the context of diabetes mellitus, particularly type 2 diabetes, where insulin secretion is impaired